Immunotherapy with iPSC-derived dendritic cells brings a new perspective to an old debate: autologous versus allogeneic? (2019)

First Author: Fairchild P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18609/cgti.2019.062

Publication URI: http://dx.doi.org/10.18609/cgti.2019.062

Type: Journal Article/Review

Parent Publication: Cell and Gene Therapy Insights

Issue: 5